In addition, SHP-1 was found to inactivate signal transducers and activators of transcription 3 (STAT3) in HER2-overexpressing breast cancer cells (data not shown), thus indicating that the tumor-suppressive effects of SHP-1 cannot be fully compromised by EGFR/Ras/Erk/GSK3β pathway inactivation. This evidence concerns the gene ERBB2 and neoplasm.